Curenetics
AI platform predicting immunotherapy response for cancer patients, clinicians, hospitals, pharmaceutical companies and CROs
Highlights
- New on EvolcAdded 2026-11-05
About Curenetics
Curenetics develops Cure-IO, a multimodal AI platform that analyzes genomic, imaging and clinical data to predict which patients may respond to immunotherapy. Its test is designed to support treatment decisions and research workflows.
The company serves patients directly as well as clinicians, hospitals, pharmaceutical companies and contract research organizations. Its offerings include clinical decision support and research services for patient stratification, biomarker discovery and trial design.
Curenetics was founded in 2018 and is headquartered in London. It describes Cure-IO as being at the proof-of-concept stage.
Product: Cure-IO, an AI platform and immunotherapy response prediction test using multimodal patient data.
Jobs at Curenetics
Leadership
- Sola Adeleke · Founder & CEOSource: company website
More health & medtech companies
Current Health
Remote monitoring and clinical support for CAR-T and other complex therapies delivered at home or in community settingsNew on EvolcRemote-friendlyCuxson Gerrard & Company
Adhesive dressings, podiatry pads and respirators made in Oldbury, UK, for medical, industrial and first aid buyersNew on EvolcCyber Media Solutions
Health and wellbeing case-management and engagement software for councils, NHS services and health providersNew on EvolcCyberliver
Regulated digital medicine and remote monitoring for patients with advanced liver disease and the clinicians managing their careNew on EvolcCyted Health
Diagnostic tests and laboratory services for clinicians assessing Barrett’s esophagus and esophageal cancerRemote-friendlyCytopath
Veterinary diagnostic pathology testing for veterinary practices and hospitals in the UK and internationallyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.